Published in Am J Respir Crit Care Med on October 31, 2008
Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol (2013) 1.65
Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab (2010) 1.34
Hypoxia and hypoxia inducible factors: diverse roles in liver diseases. Hepatology (2012) 1.32
Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) (2011) 1.32
Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease. J Pediatr (2013) 1.25
Sleep apnea predicts distinct alterations in glucose homeostasis and biomarkers in obese adults with normal and impaired glucose metabolism. Cardiovasc Diabetol (2010) 1.19
Obstructive sleep apnea, immuno-inflammation, and atherosclerosis. Semin Immunopathol (2009) 1.06
Intermittent and sustained hypoxia induce a similar gene expression profile in human aortic endothelial cells. Physiol Genomics (2010) 1.04
Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci (2014) 1.00
The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms. Diabetol Metab Syndr (2015) 1.00
Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target? Front Neurol (2012) 0.97
Chronic intermittent hypoxia induces lung growth in adult mice. Am J Physiol Lung Cell Mol Physiol (2010) 0.90
Obstructive sleep apnea syndrome and fatty liver: association or causal link? World J Gastroenterol (2010) 0.90
Adipose tissue inflammation by intermittent hypoxia: Mechanistic link between obstructive sleep apnoea and metabolic dysfunction. J Physiol (2016) 0.90
Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea. J Thorac Dis (2015) 0.87
Hypoxia and fatty liver. World J Gastroenterol (2014) 0.86
Continuous positive airway pressure improves sleep apnea associated fatty liver. Lung (2010) 0.83
Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. Am J Physiol Heart Circ Physiol (2015) 0.83
Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology. Dig Dis Sci (2015) 0.82
Sleep Disordered Breathing in Four Resource-Limited Settings in Peru: Prevalence, Risk Factors, and Association with Chronic Diseases. Sleep (2015) 0.82
Association between nocturnal hypoxia and liver injury in the setting of nonalcoholic fatty liver disease. Sleep Breath (2014) 0.82
Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea. Sleep (2015) 0.81
Elevated Serum Liver Enzymes in Patients with Obstructive Sleep Apnea-hypopnea Syndrome. Chin Med J (Engl) (2015) 0.80
The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity. Obesity (Silver Spring) (2016) 0.76
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Curr Hepatol Rep (2016) 0.75
Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease. J Hepatol (2016) 0.75
The association of obesity with insulin resistance in male patients with obstructive sleep apnea syndrome in Korea. Psychiatry Investig (2011) 0.75
Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease. PLoS One (2015) 0.75
Indices of hypoxic stress in sleep apnea. Am J Respir Crit Care Med (2009) 0.75
Obstructive sleep apnea syndrome should be considered as a cause of nocturia in younger patients without other voiding symptoms. Can Urol Assoc J (2016) 0.75
Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease. PLoS One (2016) 0.75
Impact of Obstructive Sleep Apnea on Liver Fat Accumulation According to Sex and Visceral Obesity. PLoS One (2015) 0.75
Non-alcoholic fatty liver disease: An expanded review. World J Hepatol (2017) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol (1979) 27.52
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet (2005) 17.31
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med (2004) 15.30
Steatohepatitis: a tale of two "hits"? Gastroenterology (1998) 13.21
Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med (2005) 13.14
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med (2006) 10.97
Molecular mediators of hepatic steatosis and liver injury. J Clin Invest (2004) 9.40
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA (2005) 5.74
Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol (2004) 5.26
Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med (2000) 5.13
Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology (2001) 5.07
Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med (2002) 4.35
Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab (2000) 4.34
Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med (2005) 3.73
Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA (2003) 3.51
Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med (2003) 3.42
C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation (2004) 3.25
The scoring of respiratory events in sleep: reliability and validity. J Clin Sleep Med (2007) 3.07
Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol (2003) 2.71
Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med (2007) 2.62
Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med (2005) 2.59
Pathophysiology of nonalcoholic steatohepatitis. J Clin Gastroenterol (2006) 2.59
Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol (1985) (2006) 2.39
Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol (2007) 2.28
Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med (2007) 2.09
Sleep apnea and sleep disruption in obese patients. Arch Intern Med (1994) 1.98
Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis (1991) 1.89
C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep (2007) 1.79
Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea. Chest (2008) 1.76
Chronic intermittent hypoxia predisposes to liver injury. Hepatology (2007) 1.57
Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery. Aliment Pharmacol Ther (2007) 1.53
Lessons from animal models of NASH. Hepatol Res (2005) 1.49
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol (2003) 1.44
C-reactive protein and sleep-disordered breathing. Sleep (2004) 1.41
Chronic liver injury during obstructive sleep apnea. Hepatology (2005) 1.39
Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. Sleep (2007) 1.33
Modeling hypersomnolence in sleep-disordered breathing. A novel approach using survival analysis. Am J Respir Crit Care Med (1999) 1.31
Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes Surg (2003) 1.26
Sexual influence on the control of breathing. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.22
Relationship between obstructive sleep apnea and liver abnormalities in morbidly obese patients: a prospective study. Obes Surg (2007) 1.21
Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab (2006) 1.16
Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep (2008) 1.08
Liver enzymes and histology in obese patients with obstructive sleep apnea. J Clin Gastroenterol (2007) 1.03
Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatol Res (2005) 1.02
Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis (2006) 0.92
Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Ann Hepatol (2007) 0.92
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med (2009) 8.18
Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med (2011) 7.81
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A (2013) 6.88
Brief communication: clinical implications of short-term variability in liver function test results. Ann Intern Med (2008) 5.27
Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA (2012) 5.15
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet (2011) 4.38
Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med (2002) 4.35
Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med (2013) 4.25
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92
Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med (2015) 3.79
The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis (2008) 3.69
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ (2011) 3.69
Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring) (2011) 3.62
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA (2011) 3.37
Neuromechanical control of upper airway patency during sleep. J Appl Physiol (1985) (2006) 2.93
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology (2010) 2.86
Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol (2003) 2.71
Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol (2013) 2.50
Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proc Am Thorac Soc (2008) 2.49
Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect (2006) 2.44
Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis (2007) 2.42
Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol (1985) (2006) 2.39
Impact of bariatric surgery on health care costs of obese persons: a 6-year follow-up of surgical and comparison cohorts using health plan data. JAMA Surg (2013) 2.39
New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res (2006) 2.35
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun (2004) 2.29
Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol (2007) 2.28
Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Med (2005) 2.22
Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res (2005) 2.21
Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol (2011) 2.15
Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review. Hepatology (2002) 2.13
Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physiol (1985) (2005) 2.09
Barriers to and facilitators of postpartum follow-up care in women with recent gestational diabetes mellitus: a qualitative study. J Womens Health (Larchmt) (2011) 2.05
Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest (2006) 2.03
Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res (2002) 2.00
Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases. Cancer (2013) 1.94
The effectiveness of a community/academic health center partnership in decreasing the level of blood pressure in an urban African-American population. Ethn Dis (2003) 1.94
Life-space constriction, development of frailty, and the competing risk of mortality: the Women's Health And Aging Study I. Am J Epidemiol (2007) 1.93
Independent but coordinated trials: insights from the practice-based Opportunities for Weight Reduction Trials Collaborative Research Group. Clin Trials (2010) 1.93
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. AIDS (2007) 1.92
Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis (2005) 1.91
Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care (2004) 1.90
Contribution of male sex, age, and obesity to mechanical instability of the upper airway during sleep. J Appl Physiol (1985) (2008) 1.89
The impact of obesity on breast surgery complications. Plast Reconstr Surg (2011) 1.88
Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA (2012) 1.88
Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest (2007) 1.86
Surgical site infections and cost in obese patients undergoing colorectal surgery. Arch Surg (2011) 1.78
Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol (2013) 1.77
Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. J Diabetes Complications (2008) 1.77
Effect of end-expiratory lung volume on upper airway collapsibility in sleeping men and women. J Appl Physiol (1985) (2010) 1.74
Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol (2002) 1.74
Primary liver carcinoma arising in people younger than 30 years. Am J Clin Pathol (2005) 1.66
Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program. Obesity (Silver Spring) (2010) 1.64
Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J (2009) 1.62
Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest (2005) 1.62
Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase. Circ Res (2008) 1.61
Effects of leptin and obesity on the upper airway function. J Appl Physiol (1985) (2012) 1.58
Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med (2009) 1.57
Chronic intermittent hypoxia predisposes to liver injury. Hepatology (2007) 1.57
Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology (2012) 1.57
A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol (2007) 1.55
Physician respect for patients with obesity. J Gen Intern Med (2009) 1.55
Sleep apnea in young abstinent recreational MDMA ("ecstasy") consumers. Neurology (2009) 1.54
Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. Am J Physiol Renal Physiol (2005) 1.54
Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus. Gastroenterology (2010) 1.53
Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology (2002) 1.51
Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol (2006) 1.50
Impact of bariatric surgery on health care utilization and costs among patients with diabetes. Med Care (2012) 1.49
Upper airway neuromuscular compensation during sleep is defective in obstructive sleep apnea. J Appl Physiol (1985) (2008) 1.48
Ventilating with tracheal gas insufflation and periodic tracheal occlusion during sleep and wakefulness. Chest (2002) 1.48
Association of sleep characteristics and cognition in older community-dwelling men: the MrOS sleep study. Sleep (2011) 1.48
Effect of gastric bypass surgery on kidney stone disease. J Urol (2009) 1.48
Chronic intermittent hypoxia and acetaminophen induce synergistic liver injury in mice. Exp Physiol (2008) 1.48
Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci (2004) 1.46
A simplified method for measuring critical pressures during sleep in the clinical setting. Am J Respir Crit Care Med (2004) 1.45
The association between daytime sleepiness and sleep-disordered breathing in NREM and REM sleep. Sleep (2002) 1.44
A physiologic comparison of nasal and oral positive airway pressure. Chest (2003) 1.44
Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury. Am J Surg Pathol (2013) 1.42
Treating obstructive sleep apnea with hypoglossal nerve stimulation. Sleep (2011) 1.42
Laboratory testing for and diagnosis of nutritional deficiencies in pregnancy before and after bariatric surgery. J Womens Health (Larchmt) (2013) 1.42
Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care (2010) 1.40
Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Physiol Genomics (2006) 1.38
Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. J Nerv Ment Dis (2003) 1.37
The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity (Silver Spring) (2008) 1.36
Racial and socioeconomic differences in the weight-loss experiences of obese women. Am J Public Health (2005) 1.30
Weight loss strategies associated with BMI in overweight adults with type 2 diabetes at entry into the Look AHEAD (Action for Health in Diabetes) trial. Diabetes Care (2008) 1.28
Upper airway response to electrical stimulation of the genioglossus in obstructive sleep apnea. J Appl Physiol (1985) (2003) 1.27
Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology (2003) 1.25
Does genetic ancestry explain higher values of glycated hemoglobin in African Americans? Diabetes (2011) 1.23
A nasal cannula can be used to treat obstructive sleep apnea. Am J Respir Crit Care Med (2007) 1.23
The long-term effectiveness of a lifestyle intervention in severely obese individuals. Am J Med (2013) 1.22